1 / 81

Chapter 7: Acute Respiratory Distress Syndrome

Chapter 7: Acute Respiratory Distress Syndrome. James D. Fortenberry, MD, FCCM, FAAP Medical Director, Critical Care Medicine and Pediatric/Adult ECMO Children’s Healthcare of Atlanta at Egleston. ARDS: What Is It?. Term first introduced in 1967

calliope
Download Presentation

Chapter 7: Acute Respiratory Distress Syndrome

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Chapter 7: Acute Respiratory Distress Syndrome James D. Fortenberry, MD, FCCM, FAAP Medical Director, Critical Care Medicine and Pediatric/Adult ECMO Children’s Healthcare of Atlanta at Egleston

  2. ARDS: What Is It? Term first introduced in 1967 Acute respiratory failure with non-cardiogenic pulmonary edema, capillary leak after diverse insult Adult RDS defined to differentiate from neonatal surfactant deficiency Problems with definition troubled literature Murray score 1988: CXR, PEEP, Hypoxemia, Compliance Synonyms • Shock lung • Da Nang Lung • Traumatic wet lung

  3. New and Improved Adult Respiratory Distress Syndrome Acute Respiratory Distress Syndrome

  4. ARDS: New Definition Criteria • Acute onset • Bilateral CXR infiltrates • PA pressure < 18 mm Hg • Classification • Acute lung injury - PaO2 : F1O2< 300 • Acute respiratory distress syndrome - PaO2 : F1O2< 200 -1994 American - European Consensus Conference

  5. ARDS - Epidemiology New criteria allow better estimate of incidence • 1994 criteria in Sweden: ALI 17.9/100,000; 13.5/100,000 ARDS • US: may be closer to 75/1000,000 • Prospective data pending • Incidence in children appears similar • 5-9% of PICU admissions

  6. Clinical Disorders Associated with ARDS

  7. The Problem: Lung Injury Davis et al., J Peds 1993;123:35 Non-infectious Pneumonia 14% Cardiac Arrest 12% Infectious Pneumonia 28% Hemorrhage 5% Trauma 5% Other 4% Septic Syndrome 32%

  8. ARDS - Pathogenesis Instigation • Endothelial injury: increased permeability of alveolar - capillary barrier • Epithelial injury : alveolar flood, loss of surfactant, barrier vs. infection • Pro-inflammatory mechanisms

  9. ARDS Pathogenesis: Resolution Phase Equally important • Alveolar edema - resolved by active sodium transport • Alveolar type II cells - re-epithelialize • Neutrophil clearance needed

  10. ARDS - Pathophysiology • Capillary leak:non-cardiogenic pulmonary edema • Inflammatory mediators • Diminished surfactant activity and airway collapse • Reduced lung volumes • Heterogeneous • “Baby Lungs” • Altered pulmonary hemodynamics

  11. ARDS:CT Scan View

  12. ARDS - Pathophysiology: Diminished Surfactant Activity • Surfactant production and composition altered in ARDS: low lecithin-sphingomyelin ratio • Components of edema fluid may inactivate surfactant

  13. ARDS - Pathophysiology: Diminished Surfactant Activity • Surfactant product of Type II pneumocytes • Importance of surfactant: • P = 2T/r (Laplace equation; P: trans-pulmonary pressure, T: surface tension, r: radius) • Surfactant proportions surface tension to surface area: thus

  14. ARDS - Pathophysiology: Lung Volumes • Reduced lung volumes, primarily reduced FRC • FRC = ? Nl = • Low FRC-large intrapulmonary shunt, hypoxemia • Implies • lower compliance = flatter PV curve • marked hysteresis • PV curve concave above FRC and inflection point at volume > FRC • closing volume in range of tidal volume • resistance increased primarily due to mechanical unevenness (vs. airway R): high flow rates helpful

  15. ARDS - Pathophysiology: Lung Volumes • FRC = Volume of gas in lungs at end of normal tidal expiration; outward recoil of chest wall = inward recoil of lungs • Normal FRC = • FRC decreased by 20-40% in ARDS • FRC decreased by 20-30% when supine: elevate head!

  16. ARDS - Pathophysiology: Mediators • Massive literature • Mediators involved but extent of cause/effect unknown • Cellular: • neutrophils-causative: depletion in models can obliterate lesion; ARDS can occur in neutropenic patient; direct endothelial injury, release radicals, proteolytic enzymes • macrophages-release cytokines

  17. ARDS - Pathophysiology: Mediators • Humoral: • Complement • Cytokines: TNF, IL-1 • PAF, PGs, leukotrienes • NO • Coagulant pathways

  18. ARDS - Pathophysiology:Pulmonary Edema • Non-cardiogenic pulmonary edema-Starling formula • What changes in ARDS? • Q = K(Pc - Pis) -  (pl - is) • Q = • K = • Pc = ; Pis = •  = • pl = ; is =

  19. Phases of ARDS • Acute - exudative, inflammatory: capillary congestion, neutrophil aggregation, capillary endothelial swelling, epithelial injury; hyaline membranes by 72 hours (0 - 3 days) • Sub-acute - proliferative: proliferation of type II pneumocytes (abnormal lamellar bodies with decreased surfactant), fibroblasts-intra-alveolar, widening of septae (4 - 10 days) • Chronic - fibrosing alveolitis: remodeling by collagenous tissue, arterial thickening, obliteration of pre-capillary vessels; cystic lesions ( > 10 days)

  20. ARDS - Outcomes • Most studies - mortality 40% to 60%; similar for children/adults • Death is usually due to sepsis/MODS rather than primary respiratory • Mortality may be decreasing 53/68 % 39/36 %

  21. ARDS - Principles of Therapy • Provide adequate gas exchange • Avoid secondary injury

  22. Therapies for ARDS Mechanical Ventilation Innovations: NO PLV Proning Surfactant Anti-Inflammatory Gentle ventilation: Permissive hypercapnia Low tidal volume Open-lung HFOV ARDS Extrapulmonary Gas Exchange Total Implantable Artificial Lung IVOX IV gas exchange AVCO2R ECMO

  23. The Dangers of Overdistention • Repetitive shear stress • Injury to normal alveoli • inflammatory response • air trapping • Phasic volume swings: volume trauma

  24. The Dangers of Atelectasis • compliance • intrapulmonary shunt • FiO2 • WOB • inflammatory response

  25. Lung Injury Zones Overdistention “Sweet Spot” Atelectasis

  26. ARDS: George H. W. Bush Therapy • “Kinder, gentler” forms of ventilation: • Low tidal volumes (6-8 vs.10-15 cc/kg) • “Open lung”: Higher PEEP, lower PIP • Permissive hypercapnia: tolerate higher pCO2

  27. Lower Tidal Volumes for ARDS • Multi-center trial, 861 adult ARDS • Randomized: Tidal volume 12 cc/kg Plateau pressure < 50 cm H2O vs Tidal volume 6 cc/kg Plateau pressure < 30 cm H2O ARDS Network, NEJM, 342: 2000

  28. Lower Tidal Volumes for ARDS 22% decrease * * ARDS Network, NEJM, 342: 2000 * p < .001

  29. Is turning the ARDS patient “prone” to be helpful?

  30. Prone Positioning in ARDS • Theory: let gravity improve matching perfusion to better ventilated areas • Improvement immediate • Uncertain effect on outcome

  31. Prone Positioning in Adult ARDS • Randomized trial • Standard therapy vs. standard + prone positioning • Improved oxygenation • No difference in mortality, time on ventilator, complications • Gattinoni et al., NEJM, 2001

  32. Prone Positioning in Pediatric ARDS:Longer May Be Better • Compared 6-10 hrs PP vs. 18-24 hrs PP • Overall ARDS survival 79% in 40 pts. • Relvas et al., Chest 2003

  33. Brief vs. Prolonged Prone Positioning in Children * ** Oxygenation Index (OI) * - Relvas et al., Chest 2003

  34. High Frequency Oscillation:A Whole Lotta Shakin’ Goin’ On

  35. It’s not absolute pressure, but volume or pressure swings that promote lung injury or atelectasis. - Reese Clark

  36. High Frequency Ventilation • Rapid rate • Low tidal volume • Maintain open lung • Minimal volume swings

  37. High Frequency Oscillatory Ventilation

  38. HFOV is the easiest way to find the ventilation “sweet spot”

More Related